Related references
Note: Only part of the references are listed.In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy
Kristine S. Ojala et al.
BRAIN SCIENCES (2021)
The implementation of newborn screening for spinal muscular atrophy: the Australian experience
Didu S. T. Kariyawasam et al.
GENETICS IN MEDICINE (2020)
Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
Wolfgang Mueller-Felber et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2020)
Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
Maria Jedrzejowska
DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE (2020)
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Darryl C. De Vivo et al.
NEUROMUSCULAR DISORDERS (2019)
A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
Masakazu Shinohara et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2019)
One Year of Newborn Screening for SMA - Results of a German Pilot Project
Katharina Vill et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Pilot study of population-based newborn screening for spinal muscular atrophy in New York state
Jennifer N. Kraszewski et al.
GENETICS IN MEDICINE (2018)
Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population
Felicity K. Boardman et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
Richard S. Finkel et al.
NEUROMUSCULAR DISORDERS (2018)
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Eugenio Mercuri et al.
NEUROMUSCULAR DISORDERS (2018)
Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening
Yin-Hsiu Chien et al.
JOURNAL OF PEDIATRICS (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy a literature review
Ingrid E. C. Verhaart et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy
Pei-Jung Lin et al.
PEDIATRIC NEUROLOGY (2017)
Natural history of infantile-onset spinal muscular atrophy
Stephen J. Kolb et al.
ANNALS OF NEUROLOGY (2017)
SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA
W. David Arnold et al.
MUSCLE & NERVE (2015)
Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy
Michelle A. Farrar et al.
JOURNAL OF PEDIATRICS (2013)
Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy:: three SMN2 copies fail to rescue some patients from the disease severity
Y Harada et al.
JOURNAL OF NEUROLOGY (2002)
Share Paper
